1. Home
  2. KZIA vs MCN Comparison

KZIA vs MCN Comparison

Compare KZIA & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

SELL

Current Price

$5.61

Market Cap

125.6M

Sector

Health Care

ML Signal

SELL

Logo Madison Covered Call & Equity Strategy Fund

MCN

Madison Covered Call & Equity Strategy Fund

SELL

Current Price

$5.33

Market Cap

112.7M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
KZIA
MCN
Founded
1994
2004
Country
Australia
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
112.7M
IPO Year
2002
2004

Fundamental Metrics

Financial Performance
Metric
KZIA
MCN
Price
$5.61
$5.33
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $28.76
N/A
AVG Volume (30 Days)
★ 167.6K
70.1K
Earning Date
11-27-2026
01-01-0001
Dividend Yield
N/A
★ 9.96%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.86
$5.18
52 Week High
$17.40
$6.20

Technical Indicators

Market Signals
Indicator
KZIA
MCN
Relative Strength Index (RSI) 26.35 46.09
Support Level $4.86 $5.27
Resistance Level $14.85 $5.71
Average True Range (ATR) 0.68 0.06
MACD -0.10 0.01
Stochastic Oscillator 2.75 31.58

Price Performance

Historical Comparison
KZIA
MCN

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

About MCN Madison Covered Call & Equity Strategy Fund

XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.

Share on Social Networks: